ZEB1 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma (PDAC), treatment with genotoxic agents induces shortening of ZEB1 3′UTR which increases ZEB1 protein production through escaping from repression by miRNAs such as miR-200 [186].